Condition
Mixed Mania
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
100%
3 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
3Total
P 4 (3)
Trial Status
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00732251Phase 4Terminated
Allopurinol Maintenance Study for Bipolar Disorder
NCT00643123Phase 4Completed
Allopurinol Add-on Treatment for Refractory Mania
NCT00334347Phase 4Completed
A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote DR
Showing all 3 trials